Stryker Corp

Medtronic shares slipped 0.32% to $81.67 Friday after a post-earnings rally, as strong Q4 revenue growth and a dividend hike were offset by a $250 million tariff hit and profit guidance below consensus.

Intuitive Surgical shares slipped 3.1% last week to $424.64, even as the Nasdaq and S&P 500 reached new records. Q1 revenue rose 23% to $2.77 billion, but tariff risks and a drop in bariatric procedures kept investors cautious.

Medtronic shares fell 6.1% last week to $73.81 ahead of its fiscal Q4 earnings on June 3. Options imply a 4.1% move. The company recently agreed to buy SPR Therapeutics for $650 million.

Intuitive Surgical shares slid over 4% after Goldman Sachs cut its price target to $558. The medtech giant posted strong Q1 revenue growth but faces tariff and competitive headwinds.

Medtronic shares closed at $76.15, near their 52-week low, as broader market weakness weighed ahead of the company's June 3 earnings report.

Stryker shares dropped 6.5% after Q1 earnings missed estimates due to a March cyberattack. Revenue was $6.0B vs $6.35B expected, but 2026 guidance remains unchanged.

Boston Scientific stock fell 2.6% in Monday trading, continuing last week's selloff as investors scrutinize the company's heart-rhythm device segment and Watchman demand.